ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
In-Situ 하이브리다이제이션 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 9.2%로 성장할 전망이며, 25억 3,000만 달러로 성장이 예측됩니다. 이 예측 기간의 성장은 암 이환율 상승, 유전성 질환의 발생률 증가, 맞춤형 의료에 대한 수요 증가, 동반 진단의 채용 확대, 조기 질환 진단에 대한 의식의 고조에 기인하고 있습니다. 이 기간에 예상되는 주요 동향으로는 분자진단학의 진보, ISH법의 기술적 개선, 고도의 ISH 키트 및 시약의 입수 가능성, 비침습적 진단 기술에 대한 수요 증가, 형광 In-Situ 하이브리다이제이션(FISH) 기술의 진보 등이 있습니다.
암의 이환율 증가는 향후 몇 년간의 In-Situ 하이브리다이제이션 시장의 성장을 가속할 것으로 예측됩니다. 암은 이상 세포의 통제 불가능한 증식을 특징으로 하는 질환으로 주변 조직에 침윤하거나 신체의 다른 부위로 전이될 수 있습니다. 암 환자의 증가는 주로 평균 수명의 연장에 기인하고 있으며, 나이가 들면서 유전자 돌연변이가 축적되거나 암을 일으키는 물질에 노출될 가능성이 높아지기 때문입니다. In-Situ 하이브리데이제이션(ISH)은 종양세포 내 특정 유전자 이상을 검출함으로써 암 관리에 중요한 역할을 하고 있습니다. ISH는 정확한 진단, 예후를 지원해 표적 치료 결정을 돕습니다. 예를 들어 2024년 2월 스위스에 본부를 둔 정부 간 기관인 세계보건기구(WHO)는 새로운 암 사례가 2050년까지 3,500만 명을 넘어설 것으로 예측하고 있으며, 2022년 추정 2,000만 증례에서 77% 증가할 것이라고 보고했습니다. 이처럼 암 이환율의 증가는 In-Situ 하이브리다이제이션 시장의 확대를 가속화시킬 것으로 예상됩니다.
In-Situ 하이브리다이제이션 시장의 주요 기업은 표적 치료에 대한 환자의 반응을 보다 정확하게 예측하기 위해 HER2 검사 기술 등의 선진 솔루션의 개발에 주력하고 있습니다. HER2 검사 솔루션은 암세포에서 HER2 단백질의 존재와 발현 수준을 검출하도록 설계된 진단 도구로, 맞춤형 치료 전략을 지원합니다. 예를 들면, 2023년 12월, 인도를 거점으로 하는 암 진단 서비스의 프로바이더인 Cytelabs사는, 유방암 환자를 대상으로 한 dual in situ hybridization(DISH) 검사를 도입했습니다. 미국 FDA 승인을 받은 이 DISH 기술은 효과적인 표적 유방암 치료에 필수적인 HER2 검사의 정확도를 크게 향상시켰습니다. 이 방법은 24시간에서 48시간 이내에 HER2 상태 결과를 내놓음으로써 대기시간을 대폭 단축하고 환자와 그 가족의 정신적 부담을 줄이는 데 도움이 됩니다. 신뢰할 수 있고 시의적절한 결과를 제공함으로써 DISH는 조기 치료 계획과 시작을 용이하게 합니다. HER2 상태는 예후와 치료 접근 방식을 모두 결정하는 중요한 인자이기 때문에 정확하고 신속한 검사는 모든 침윤성 유방암의 효과적인 평가에 필수적입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 In-Situ 하이브리다이제이션 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 In-Situ 하이브리다이제이션 시장 : 성장률 분석
세계의 In-Situ 하이브리다이제이션 시장 실적 : 규모 및 성장(2019-2024년)
세계의 In-Situ 하이브리다이제이션 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 In-Situ 하이브리다이제이션 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 In-Situ 하이브리다이제이션 시장 : 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
분석기기
키트 및 시약
소프트웨어 및 서비스
기타 제품
세계의 In-Situ 하이브리다이제이션 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
형광 In-Situ 하이브리다이제이션
크로모제닉 In-Situ 하이브리다이제이션
듀얼 컬러 In-Situ 하이브리다이제이션
세계의 In-Situ 하이브리다이제이션 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
암 진단
세포유전학
발생 생물학
감염증
면역학
기타 용도
세계의 In-Situ 하이브리다이제이션 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진단실험실
학술 연구기관
계약 연구기관
제약 및 생명 공학 기업
세계의 In-Situ 하이브리다이제이션 시장 : 분석 기기 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
형광 현미경
명시야 현미경
자동 슬라이드 스캐너
하이브리드화 시스템
세계의 In-Situ 하이브리다이제이션 시장 : 키트 및 시약 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
DNA 프로브
RNA 프로브
라벨링 키트
검출 시약
전처리 시약
세계의 In-Situ 하이브리다이제이션 시장 : 소프트웨어 및 서비스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
화상 해석 소프트웨어
데이터 관리 소프트웨어
커스텀 프로브 설계 서비스
샘플 준비 서비스
세계의 In-Situ 하이브리다이제이션 시장 : 기타 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
슬라이드 및 커버 유리
보존 시약
하이브리드화 버퍼
제어 프로브
제7장 지역별 및 국가별 분석
세계의 In-Situ 하이브리다이제이션 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 In-Situ 하이브리다이제이션 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
In-Situ 하이브리다이제이션 시장 : 경쟁 구도
In-Situ 하이브리다이제이션 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Agilent Technologies Inc.
PerkinElmer Inc.
Bio-Rad Laboratories Inc.
Qiagen NV
Bio-Techne Corporation
Leica Biosystems Nussloch GmbH
Biocare Medical LLC
BioGenex Srl
Oxford Gene Technology Inc.
BioDot Inc.
Creative Biolabs
West Medica Produktions-und Handels GmbH
Empire Genomics LLC
Abnova Corporation
BioView Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
In-Situ 하이브리다이제이션 시장(2029년) : 새로운 기회를 제공하는 국가
In-Situ 하이브리다이제이션 시장(2029년) : 새로운 기회를 제공하는 부문
In-Situ 하이브리다이제이션 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
In-situ hybridization (ISH) is a molecular technique used to detect and visualize specific DNA or RNA sequences within preserved cells or tissue samples. It functions by applying labeled complementary probes that bind to the target genetic sequences, enabling researchers to observe the localization of specific genes or transcripts while maintaining the integrity of the tissue structure. ISH is widely employed in both research and clinical environments to analyze gene expression, identify chromosomal abnormalities, detect viral infections, and assist in cancer diagnosis, offering comprehensive spatial and molecular insights within biological specimens.
The primary products associated with in-situ hybridization include analytical instruments, kits and reagents, software and services, and other components. Analytical instruments are specialized tools used to detect, measure, and analyze biological, chemical, or physical characteristics within a sample. This technique utilizes several technologies such as fluorescence in situ hybridization, chromogenic in situ hybridization, and dual-color in situ hybridization. It is applied in areas such as cancer diagnosis, cytogenetics, developmental biology, infectious diseases, and immunology. End users include hospitals and diagnostic laboratories, academic and research institutions, contract research organizations, and pharmaceutical and biotechnology companies.
The in-situ hybridization market research report is one of a series of new reports from The Business Research Company that provides in-situ hybridization market statistics, including in-situ hybridization industry global market size, regional shares, competitors with a in-situ hybridization market share, detailed in-situ hybridization market segments, market trends and opportunities, and any further data you may need to thrive in the in-situ hybridization industry. This in-situ hybridization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The in-situ hybridization market size has grown strongly in recent years. It will grow from $1.62 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to increased research and development activities, the expansion of biopharmaceutical research, growing government support for genomic research, rising demand for precision medicine therapies, and a higher number of clinical trials utilizing in-situ hybridization (ISH).
The in situ hybridization market size is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the rising prevalence of cancer, increasing incidence of genetic disorders, growing demand for personalized medicine, greater adoption of companion diagnostics, and heightened awareness regarding early disease diagnosis. Key trends expected during this period include advancements in molecular diagnostics, technological improvements in ISH methods, availability of advanced ISH kits and reagents, increasing demand for non-invasive diagnostic techniques, and progress in fluorescence in-situ hybridization (FISH) technologies.
The increasing incidence of cancer is expected to drive the growth of the in-situ hybridization market in the coming years. Cancer is a disease characterized by the uncontrolled growth of abnormal cells, which can invade surrounding tissues or spread to other parts of the body. The rise in cancer cases is primarily attributed to longer life expectancy, as aging increases the likelihood of accumulating genetic mutations and exposure to cancer-causing agents. In-situ hybridization (ISH) plays a critical role in cancer management by detecting specific genetic abnormalities within tumor cells. It supports accurate diagnosis, prognosis, and helps guide decisions for targeted therapies. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental body, reported that new cancer cases are projected to surpass 35 million by 2050, representing a 77% increase from an estimated 20 million cases in 2022. Thus, the growing incidence of cancer is expected to accelerate the expansion of the in-situ hybridization market.
Leading companies in the in-situ hybridization market are concentrating on the development of advanced solutions, such as HER2 testing technologies, to better predict patient response to targeted treatments. HER2 testing solutions are diagnostic tools designed to detect the presence and expression levels of the HER2 protein in cancer cells, supporting personalized treatment strategies. For example, in December 2023, Cytelabs, an India-based provider of cancer diagnostic services, introduced dual in situ hybridization (DISH) testing for breast cancer patients. This DISH technology, approved by the US FDA, marks a significant advancement in the precision of HER2 testing, which is crucial for effective targeted breast cancer therapy. The method significantly reduces waiting times by delivering HER2 status results within 24 to 48 hours, helping to alleviate the emotional burden on patients and their families. By offering reliable and timely results, DISH facilitates early treatment planning and initiation. As HER2 status is a key factor in determining both prognosis and therapeutic approach, accurate and prompt testing is essential for the effective evaluation of all invasive breast cancers.
In January 2025, Leica Biosystems, a Germany-based biotechnology firm, formed a partnership with Molecular Instruments to enable comprehensive RNA-ISH workflows using the BOND RX and BOND RXm research staining platforms. This collaboration integrates HCR Pro RNA-ISH with Leica Biosystems' existing BOND immunohistochemistry and immunofluorescence methods, enabling the concurrent detection of RNA and proteins within the same tissue section. This advancement provides researchers with enhanced spatial resolution while conserving scarce tissue samples. Molecular Instruments is a biotechnology company based in the United States.
Major players in the in-situ hybridization market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Biocare Medical LLC, BioGenex Srl, Oxford Gene Technology Inc., BioDot Inc., Creative Biolabs, West Medica Produktions- und Handels GmbH, Empire Genomics LLC, Abnova Corporation, BioView Ltd., Advanced Cell Diagnostics Inc., BioCat GmbH, VERMICON AG, Bio SB Inc., Genemed Biotechnologies Inc.
North America was the largest region in the in-situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in-situ hybridization report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the in-situ hybridization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in-situ hybridization market consists of revenues earned by entities by providing services such as custom probe design, tissue sample preparation, assay development, multiplexing services, and validation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in-situ hybridization market also includes sales of slide processing equipment, positive and negative control slides, hybridization chambers, and nuclease-free consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In-Situ Hybridization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in-situ hybridization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for in-situ hybridization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-situ hybridization market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Analytical Instruments; Kits And Reagents; Software And Services; Other Products
2) By Technology: Fluorescence In Situ Hybridization; Chromogenic In Situ Hybridization; Dual-Color In Situ Hybridization
3) By Application: Cancer Diagnosis; Cytogenetics; Developmental Biology; Infectious Diseases; Immunology; Other Applications
4) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Contract Research Organizations; Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes; Brightfield Microscopes; Automated Slide Scanners; Hybridization Systems
2) By Kits And Reagents: DNA Probes; RNA Probes; Labeling Kits; Detection Reagents; Pretreatment Reagents
3) By Software And Services: Image Analysis Software; Data Management Software; Custom Probe Design Services; Sample Preparation Services
4) By Other Products: Slides And Coverslips; Storage Reagents; Hybridization Buffers; Control Probes
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. In-Situ Hybridization Market Characteristics
3. In-Situ Hybridization Market Trends And Strategies
4. In-Situ Hybridization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global In-Situ Hybridization Growth Analysis And Strategic Analysis Framework
5.1. Global In-Situ Hybridization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global In-Situ Hybridization Market Growth Rate Analysis
5.4. Global In-Situ Hybridization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global In-Situ Hybridization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global In-Situ Hybridization Total Addressable Market (TAM)
6. In-Situ Hybridization Market Segmentation
6.1. Global In-Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analytical Instruments
Kits And Reagents
Software And Services
Other Products
6.2. Global In-Situ Hybridization Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescence In Situ Hybridization
Chromogenic In Situ Hybridization
Dual-Color In Situ Hybridization
6.3. Global In-Situ Hybridization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Diagnosis
Cytogenetics
Developmental Biology
Infectious Diseases
Immunology
Other Applications
6.4. Global In-Situ Hybridization Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Laboratories
Academic And Research Institutes
Contract Research Organizations
Pharmaceutical And Biotechnology Companies
6.5. Global In-Situ Hybridization Market, Sub-Segmentation Of Analytical Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescence Microscopes
Brightfield Microscopes
Automated Slide Scanners
Hybridization Systems
6.6. Global In-Situ Hybridization Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Probes
RNA Probes
Labeling Kits
Detection Reagents
Pretreatment Reagents
6.7. Global In-Situ Hybridization Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Image Analysis Software
Data Management Software
Custom Probe Design Services
Sample Preparation Services
6.8. Global In-Situ Hybridization Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Slides And Coverslips
Storage Reagents
Hybridization Buffers
Control Probes
7. In-Situ Hybridization Market Regional And Country Analysis
7.1. Global In-Situ Hybridization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global In-Situ Hybridization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
